Analysis of the Influence of Serum MMP-2 and vWF Levels on the Predictive Value of Risk Grade and Prognosis of Patients with Acute Myeloid Leukemia

Table 2

vWF level changes in the three groups (‾x ± s, %).

Group	Pretherapy	Posttreatment
A group (n = 32)	213.14 ± 109.23	174.23 ± 98.42
B group (n = 46)	231.55 ± 114.31^a	193.23 ± 86.23^a
C group (n = 27)	263.29 ± 100.32^ab	220.65 ± 96.44^ab
F	20.131	21.112
	<0.001	<0.001